Analysis of the Clinical Effect of Botulinumtoxin Type A(Botox-A)Combined with Electromyographic Biofeedback Therapy on the Upper Limb Muscle Spasm after Stroke
10.13241/j.cnki.pmb.2017.27.031
- VernacularTitle:A型肉毒毒素联合肌电生物反馈治疗脑卒中后上肢肌痉挛的临床疗效分析
- Author:
Ying QU
;
Lei SHAN
;
Changxi LIU
;
Ke ZHAO
;
Runan XIAO
;
Xiaoting SHEN
- Keywords:
Stroke;
Upper limb muscular spasticity;
Botulinumtoxin type A;
Electromyographic biofeedback
- From:
Progress in Modern Biomedicine
2017;17(27):5323-5326
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical effect of botulinumtoxin type A (Botox-A) combined with electromyographic biofeedback therapy on the upper limb muscle spasm after stroke.Methods:86 cases of patients with upper limb muscle spasm after stroke in our hospital from January 2016 to January 2017 were selected and divided into the observation group and the control group,with 43 cases in each group.Patients in the control group were treated with electromyographic biofeedback therapy,and the observation group was treated with Botox-A based on the basis of control group.The improvement of upper limb muscle spasm,Upper limb movement function,the active range of wrist joint and life skills before and after treatment were compared between two groups.Results:After treatment,the total effective rate of improvement of upper limb muscle spasm of observation group were significantly higher than that of the control group (P＜0.05);At 2 weeks and 4 weeks after treatment,the Fugl-Meyer scores,Wrist joint activities,modified Barthel index (MBI) of two groups were significantly higher than those before treatment (P＜0.05),which were significantly higher in the observation group than those of the control group (P＜0.05).Conclusion:Botox-Acombined with electromyographic biofeedback therapy had remarkable clinical effect on the upper limb muscle spasm after stroke,which could effectively reduce the upper limb spasticity,improve the arm and wrist movement ability and the ability of daily life.
